|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||298,450.00 - 301,680.00|
|52 Week Range||242,180.00 - 326,350.00|
|PE Ratio (TTM)||10.98|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||348,875.00|
Yahoo Finance is the exclusive online host of the Berkshire Hathaway 2018 Annual Shareholders Meeting, coming Saturday, May 5th.
The company has set its ambitions on reducing the shortage of doctors and nurses at U.S. hospitals via the creation of an online-only marketplace for clinical jobs. “There is a huge shortage of doctors in the U.S., along with nurses and other health-care professionals,” says Alexi Nazem, Nomad’s CEO, who co-founded the company in 2015. The shortage, and the high cost of hospital administration, is traceable in part to an arcane health-care staffing system called locum tenens – a Latin phrase that roughly means “to hold a place.” The locums market, as it is known, is a 50-year-old industry reliant on brokers and recruiters who place doctors and nurses with hospitals in return for a finder’s fee from the hospitals.
Berkshire Hathaway (BRK/B), the well-known Warren Buffett investment vehicle for the last 50 years, has been the subject of many good notes and discussions. In this note I will briefly cover general background and then discuss a few key topics as to why NOT to buy BRK, and will try to defend my thesis. General background BRK’s business model is unique.
The Zacks Analyst Blog Highlights: AbbVie, Berkshire Hathaway, PepsiCo, BP and Twenty-First Century Fox
Jim Cramer zips through his take on callers' favorite stocks, including that of a company in the middle of a major deal.